fda drug shortage semaglutide The Ozempic Is Over On February 21, 2025, the

The ClinicalTrials.gov database provides international trial listings and can be searched using the term 'retatrutide' or the compound identifier 'LY3437943'

This product is intended exclusively for in vitro and laboratory research

(2.1) Prior to initiation, assess renal function with estimated glomerular filtration rate (eGFR) (2.2) Do not use in patients with eGFR below 30 mL/min/1.73 m2

The GLP-1 receptor is present in neurons and glial cells in several brain regions (Diz-Chaves et al., 2022b)

As far as I know, there has been no head-to-head trial comparing these four therapeutics using the same methodology, populations, or endpoints